The (-590 C/T) polymorphism in the interleukin-4 gene is associated with increased risk for early stages of corolectal adenocarcinoma

In Vivo. 2007 Nov-Dec;21(6):1031-5.

Abstract

Background: In the light of the known association between several carcinomas and the -590C/T polymorphism, which affects transcription of the antitumor interleukin-4 (IL-4) gene, the purpose of this study was to investigate the possible contribution of this polymorphism to the development of colorectal cancer.

Materials and methods: The -590C/T polymorphism was examined in DNA samples of 93 patients with colorectal cancer (adenocarcinomas) and 108 healthy controls of comparable ethnicity, age and gender.

Results: The detected allele and carrier frequencies for the high expression T allele in the patient group were significantly decreased in comparison with that of the control group (13.44% versus 22.22%, and 21.51% versus 36.11%, respectively, p<0.01). The same pattern was observed between controls and patients in initial cancer stages.

Conclusion: These findings indicate that IL-4 gene expression-related polymorphism is associated with the development of initial stages of colorectal cancer, while in advanced stages IL-4 levels appear to be less important.

MeSH terms

  • Adenocarcinoma / genetics*
  • Alleles
  • Colorectal Neoplasms / genetics*
  • Gene Frequency
  • Humans
  • Interleukin-4 / genetics*
  • Polymorphism, Genetic*
  • Risk Factors

Substances

  • Interleukin-4